1600-6143/asset/olbannerleft.gif?v=1&s=c46a3f174bfd9c6eb548cc809401524372c32e90)
1600-6143/asset/olbannerright.gif?v=1&s=9fc9790fa8ad5ef85aeaf408bf0d3d969d2fc012)
Long-term Management of the Liver Transplant Patient: Recommendations for the Primary Care Doctor
Article first published online: 26 JUN 2009
DOI: 10.1111/j.1600-6143.2009.02733.x
© 2009 The Authors Journal compilation © 2009 The American Society of Transplantation and the American Society of Transplant Surgeons
Additional Information
How to Cite
McGuire, B. M., Rosenthal, P., Brown, C. C., Busch, A. M. H., Calcatera, S. M., Claria, R. S., Hunt, N. K., Korenblat, K. M., Mazariegos, G. V., Moonka, D., Orloff, S. L., Perry, D. K., Rosen, C. B., Scott, D. L. and Sudan, D. L. (2009), Long-term Management of the Liver Transplant Patient: Recommendations for the Primary Care Doctor. American Journal of Transplantation, 9: 1988–2003. doi: 10.1111/j.1600-6143.2009.02733.x
Publication History
- Issue published online: 20 AUG 2009
- Article first published online: 26 JUN 2009
- Received 08 September 2008, revised 07 April 2009 and accepted for publication 30 April 2009
- Abstract
- Article
- References
- Cited By
Keywords:
- Immunosuppression;
- liver;
- long-term;
- management;
- transplantation
These guidelines, intended to assist primary care providers in managing liver transplant patients, address drug interactions and side effects of immunosuppressive agents, allograft dysfunction, renal dysfunction, metabolic disorders, malignancies, productivity in the workforce, pregnancy and sexual function, and pediatric concerns.
No official document has been published for primary care physicians regarding the management of liver transplant patients. With no official source of reference, primary care physicians often question their care of these patients. The following guidelines have been approved by the American Society of Transplantation and represent the position of the association. The data presented are based on formal review and analysis of published literature in the field and the clinical experience of the authors. These guidelines address drug interactions and side effects of immunosuppressive agents, allograft dysfunction, renal dysfunction, metabolic disorders, preventive medicine, malignancies, disability and productivity in the workforce, issues specific to pregnancy and sexual function, and pediatric patient concerns. These guidelines are intended to provide a bridge between transplant centers and primary care physicians in the long-term management of the liver transplant patient.